Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of PBI-100 Topical Cream in Healthy Adults and Psoriasis Subjects
NCT05514353Phase 1Completed
- Sponsor
- Pyramid Biosciences
- Start
- Dec 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in psoriasis comparing PBI-100 Topical Cream with Vehicle Cream (2 arms). Primary endpoints: Number of Adverse Events (AEs) in Healthy Adult Subjects at Day 28 and Number of Adverse Events (AEs) in Adult Subjects with Psoriasis at Day 28. Started Dec 2021; status: completed.
02
Drugs
PBI-100
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT05514353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514353.